Several analysts have recently updated their ratings and price targets for Imperva (NYSE: IMPV): 6/21/2016 – Imperva had its “buy” rating reaffirmed by analysts at Oppenheimer. They now have a $60.00 price target on the stock. 6/21/2016 – Imperva had its “buy” rating reaffirmed by analysts at Nomura. They now have a $60.00 price target […]
